Thursday, April 08, 2021 5:06:41 AM
It could be window dressing, like a lot of things NWBO did over the past 12 to 24 months, if you follow Ex’s and LC’s 'kicking the can down the road and collecting salaries and boni a long the way‘ narrative.
If you disagree with that narrative, the understanding about this hire could be as follows:
-She is Canada based so she will be the liaison person for everything that’s Canada related. After all the Canadian RA is one of the four RAs NWBO is focused on. According to her LinkedIn profile she has experience in dealing with bureaucratic institutions.
-There might be the need for NWBO to have a legal entity in Canada (if they haven’t one already) which would then be in need of a figurehead.
-I don’t want to be disrespectful but on her LinkedIn profile she mentions that she was a Manager at Deloitte. That’s not high ranking I suppose. So she wasn’t a very senior person at Deloitte supposedly. And she seemed to be involved in all sorts of different financial and regulatory activities, i.e. not really specialising in one field like e.g. M&A. To me that would rule out that she would ‚lead‘ any BO preparation or negotiations. But it seems she is used to and knows how to do the leg work. And she is experienced enough to understand how „things work“. That’s where the value of her might lie when it comes to NWBO.
If NWBO is following a strategy of going it alone until success or BO they need more people who understand to do the heavy lifting and who are not as expensive as outside consultants and advisors.
So the hire could make sense for NWBO given the Canadian angle and the simple pair of hard working hands.
If you disagree with that narrative, the understanding about this hire could be as follows:
-She is Canada based so she will be the liaison person for everything that’s Canada related. After all the Canadian RA is one of the four RAs NWBO is focused on. According to her LinkedIn profile she has experience in dealing with bureaucratic institutions.
-There might be the need for NWBO to have a legal entity in Canada (if they haven’t one already) which would then be in need of a figurehead.
-I don’t want to be disrespectful but on her LinkedIn profile she mentions that she was a Manager at Deloitte. That’s not high ranking I suppose. So she wasn’t a very senior person at Deloitte supposedly. And she seemed to be involved in all sorts of different financial and regulatory activities, i.e. not really specialising in one field like e.g. M&A. To me that would rule out that she would ‚lead‘ any BO preparation or negotiations. But it seems she is used to and knows how to do the leg work. And she is experienced enough to understand how „things work“. That’s where the value of her might lie when it comes to NWBO.
If NWBO is following a strategy of going it alone until success or BO they need more people who understand to do the heavy lifting and who are not as expensive as outside consultants and advisors.
So the hire could make sense for NWBO given the Canadian angle and the simple pair of hard working hands.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
